A Phase II Study of Maintenance With Azacitidine in MDS Patients

Clinical trial NCT00446303 · TERMINATED

Trial details

NCT number: NCT00446303
Sponsor: Groupe Francophone des Myelodysplasies
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myelocytic, Acute Myelodysplastic Syndromes

Start date: 2006-07-01
Primary completion: 2010-07-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.